Volume 85 Issue 24 | p. 17 | Concentrates
Issue Date: June 11, 2007

Qiagen Acquires Diagnostics Firm

Department: Business

Qiagen, a Dutch supplier of samples and assays for biotechnology research, will acquire Maryland-based Digene in a stock and cash deal valued at about $1.6 billion. Qiagen provides assay technologies for biological targets such as DNA, RNA, and proteins. It will obtain Diagene's diagnostic technology for screening human papillomavirus, the only HPV screening technology approved in the U.S. and Europe.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment